The FMS-like tyrosine kinase-3 (FLT3), a tyrosine kinase receptor, was one of the most frequently mutated genes in AML and accounted for approximately 30% of AML cases [2]. This evidence concerns the gene FLT3 and acute myeloid leukemia.